3638
H. Shirouzu et al. / Tetrahedron 70 (2014) 3635e3639
DMSO-d6)
d
2.63 (s, 3H), 7.37 (tt, J¼7.3 and 1.4 Hz, 1H), 7.47 (m, 2H),
4.5. General procedure for gram-scale N-glycosylation
7.62 (dd, J¼8.5 and 2.0 Hz, 1H), 7.68e7.74 (m, 3H), 7.91 (d, J¼1.5 Hz,
1H); 13C NMR (125 MHz, DMSO-d6)
d
14.2, 110.6, 116.9, 117.1, 120.7
A mixture of 5-fluorouracil (339.1 mg, 2.6 mmol), pyridine
(2.0 mL), and HMDS (4.0 mL) in an 80-mL Schlenk tube was
refluxed for ca. 30 min to give a clear solution of 2a. Then, all the
volatiles were removed under reduced pressure (ca. 1 mmHg) to
give a clear syrup, which was dissolved in acetone (20 mL). To this
were added 1 (1.02 g, 2.0 mmol) and 7b (30.5 mg, 0.10 mmol,
5 mol %) and the mixture was stirred under refluxing for 6 h. After
the mixture was cooled to 0 ꢀC, EtOAc (15 mL) and MeOH (2.0 mL)
were added, while stirring at 0 ꢀC for 15 min. The solvent was
evaporated to less than 10 mL, and the residue was diluted with
EtOAc (300 mL) and washed with a saturated NaHCO3 aq (100 mL).
After the organic phase was separated, it was washed with a sat-
urated NaHCO3 aq (100 mLꢁ2) and brine (100 mL) then dried with
Na2SO4. Evaporation of the solvent afforded the crude product,
which was purified by recrystallization from EtOAc (ca. 31 mL) and
hexane (ca. 30 mL) to give 20,30,50-tri-O-benzoyl-5-fluorouridine
(3a) (1.05 g, 91%) as a white powder. Spectral data were consistent
(CF3, q, J¼321 Hz), 123.7, 127.1, 127.3, 129.0, 137.0, 140.2, 142.0, 150.4,
164.7.
4.3.2. 1-Methylbenzimidazolium perchlorate (4b). Compound 4b
(2.86 g, 91%) was obtained under the following conditions: 1-
methylbenzimidazole (1.78 g, 14 mmol), 70% aqueous perchloric
acid (1.16 mL, 14 mmol), CH2Cl2 (5.0 mL), Et2O (280 mL). Mp
120e121 ꢀC; [found: C, 41.14; H, 3.89; N,12.00. C8H9ClN2O4 requires
C, 41.31; H, 3.90; N, 12.04.]; IR (KBr) 3161, 1992, 1614, 1564, 1454,
1361, 1272 cmꢂ1; 1H NMR (500 MHz, DMSO-d6)
(m, 2H), 7.87 (m, 1H), 7.99 (m, 1H), 9.54 (s, 1H); 13C NMR (125 MHz,
DMSO-d6) 33.0, 113.2, 114.8, 126.0, 126.4, 130.8, 131.8, 142.1.
d 4.08 (s, 3H), 7.64
d
4.3.3. 2,6-Di-tert-butyl-4-methylpyridinium
perchlorate
(5b). Compound 5b (2.28 g, 89%) was obtained under the following
conditions: 2,6-di-tert-butyl-4-methylpyridine (1.71 g, 8.3 mmol),
70% aqueous perchloric acid (0.72 mL, 8.3 mmol), CH2Cl2 (2.0 mL),
Et2O (190 mL). Mp 253.0e255.3 ꢀC; [found: C, 54.82; H, 7.95; N,
4.57. C14H24ClNO4 requires C, 54.99; H, 7.91; N, 4.58.]; IR (KBr) 3391,
2971, 2874, 1637, 1620, 1482, 1375, 1253 cmꢂ1; 1H NMR (500 MHz,
with the reported ones.6 Found: C, 62.65; H, 4.06; N, 4.82.
22
C
30H23FN2O9 requires C, 62.72; H, 4.04; N, 4.88. [
a
]
D
ꢂ63.3ꢃ1.2 (c
0.100, CHCl3)21 1H NMR (500 MHz, DMSO-d6)
;
d
4.67 (dd, J¼11.8
and 5.5 Hz, 1H), 4.70e4.79 (m, 2H), 5.88e5.94 (m, 2H), 6.17 (d,
J¼3.5 Hz, 1H), 7.41e7.47 (m, 4H), 7.50 (dd, J¼8.0 and 7.5 Hz, 2H),
7.65 (m, 3H), 7.88 (dd, J¼8.0 and 1.0 Hz, 4H), 8.01 (dd, J¼8.0 and
1.0 Hz, 2H), 8.21(d, J¼7.0 Hz, 1H), 12.0 (s, 1H); 13C NMR (125 MHz,
CD3CN)
CD3CN)
d
1.50 (s, 18H), 2.60 (s, 3H), 7.73 (s, 2H); 13C NMR (125 MHz,
22.7, 28.9, 37.3, 124.2, 162.9.
d
4.3.4. 2-Methyl-5-phenylbenzoxazolium perchlorate (7b).14 Com
pound 7b (5.77 g, 78%) was obtained under the following condi-
tions: 2-methyl-5-phenylbenzoxazole (5.00 g, 24 mmol), 70%
aqueous perchloric acid (2.06 mL, 25 mmol), CH2Cl2 (40 mL), Et2O
(300 mL). Mp 208e211 ꢀC (lit.14 mp 204 ꢀC); [found: C, 54.19; H,
3.87; N, 4.24. C14H12ClNO5 requires C, 54.29; H, 3.91; N, 4.52.]; IR
DMSO-d6)
d
63.7, 70.3, 73.1, 78.9, 88.9, 126.1 (C-6, JCeF¼34 Hz),
128.4, 128.5, 128.7, 128.8, 129.2, 129.30, 129.31, 129.4, 133.6, 133.9,
134.0, 140.2 (C-5, JCeF¼230 Hz), 149.0, 157.1 (C-4, JCeF¼25 Hz),
164.6, 165.5.
Acknowledgements
(KBr) 3037, 1634, 1614, 1457, 1430, 1403, 1307 cmꢂ1
(500 MHz, DMSO-d6)
;
1H NMR
2.63 (s, 3H), 7.37 (t, J¼7.5 Hz, 1H), 7.47
d
We are grateful to Dr. Kin-ichi Oyama (Nagoya University) for his
valuable comments on the manuscript and for conducting the el-
emental analyses and the MS measurements. We also thank Pro-
fessors Kumi Yoshida and Tadao Kondo (Nagoya University) for the
helpful discussions. This work was financially supported by Nagoya
University (691445).
(dd, J¼8.0 and 7.5 Hz, 2H), 7.62 (dd, J¼8.5 and 2.0 Hz, 1H), 7.69e7.73
(m, 3H), 7.90 (d, J¼1.5 Hz, 1H); 13C NMR (125 MHz, DMSO-d6)
d
14.2, 110.6, 117.1, 123.7, 127.1, 127.3, 129.0, 137.0, 140.1, 142.0, 150.0,
164.6.
4.4. Catalyst screening
Supplementary data
A mixture of 5-fluorouracil (16.9 mg, 0.13 mmol), pyridine
(0.20 mL), and hexamethyldisilazane (HMDS) (0.40 mL) in a 20-
mL Schlenk tube was refluxed for ca. 30 min to give a clear so-
lution of 2a. Then, all the volatiles were removed under reduced
pressure (ca. 1 mmHg) to give a clear syrup, which was dissolved
in MeCN (1.0 mL). To this were added 1-O-acetyl-2,3,5-tri-O-
Supplementary data related to this article can be found at http://
References and notes
benzoyl-
(1.5 mg, 5
b
-
m
D
-ribofuranose (1) (50.5 mg, 0.10 mmol) and 7b
mol) and the mixture was stirred under reflux for 2 h.
After the mixture was cooled to rt, an aliquot (50
m
L) was taken
from the mixture and quenched with MeOH (0.5 mL). After re-
moval of the volatile, the yield was calculated to be 80% by
€
comparison of the 1H NMR signal ratio at
d 6.30 (s, C(1)H of 1),
€
6.16 (d, J¼4.0 Hz, C(10)H of 3a), and
d
8.35 (d, J¼7.0 Hz, C(6)H of
d
8) in DMSO-d6 (Table 1, entry 8). In the case of the TMSOTf-
catalyzed reaction, MeCN or acetone (3.0 mL) solution of
TMSOTf (27
solution (0.10 mL, 5
1 and 2a in MeCN or acetone (0.90 mL). In the case of the SnCl4-
catalyzed reaction, MeCN or acetone (3.0 mL) solution of SnCl4
m
L, 150
m
mol) was prepared and an aliquot of the
m
mol) was immediately added to a mixture of
(18
(0.10 mL, 5
in MeCN or acetone (0.90 mL). In the case of the HClO4-catalyzed
reaction, 0.1 mol/L dioxane solution (50 L) of HClO4 was added to
the solution (950 L) of 1 and 2a. In a similar manner, reactions
were conducted in different conditions shown in Table 1.
m
L, 150
m
mol) was prepared and an aliquot of the solution
m
mol) was immediately added to a mixture of 1 and 2a
m
m
€